Elsevier

Neurobiology of Aging

Volume 21, Issue 2, March–April 2000, Pages 293-300
Neurobiology of Aging

Neuroimaging
How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer’s disease? A review of neuroimaging studies

https://doi.org/10.1016/S0197-4580(00)00120-2Get rights and content

Abstract

The ϵ4 allele of apolipoprotein E is a risk factor for Alzheimer’s disease, but also a modulator of its clinical picture. In this paper, recent research in neuroimaging of aging and Alzheimer’s disease in relation to apolipoprotein E is reviewed, emphasizing the advances but also the controversies. Further, the possible clinicopathological implications of these findings are discussed.

Introduction

Whereas the apolipoprotein E (ApoE) allele ϵ4 is the most significant risk factor for Alzheimer’s disease (AD) in the general population, research on the role of ApoE in relation to the pathogenesis of AD has provoked several controversies, and the exact role of the ApoE remains undetermined. For instance, it was initially reported that brains of AD patients carrying the ϵ4 allele had increased number of plaques [21], [33], [39], [41], [46], neurofibrillary tangles [33], [34], [39], and more severe cholinergic deficit [38], [50], [51] than found in those without the ϵ4 allele. These, however, were followed by subsequent studies that could not replicate or even totally contradicted these findings [4], [14], [18]. Since the primary purpose of this paper is to review neuroimaging findings in AD in relation with the ApoE genotype, we leave this debate open, and instead focus on the findings, and the controversies, that neuroimaging studies to date have suggested. We will propose that ApoE may be related with asymmetrical and regionally different patterns of AD, histopathological background of which remains unknown. By presenting these intriguing controversies, we hope that this review will be of interest even to those who are not directly involved with the field of neuroimaging.

Section snippets

ApoE and magnetic resonance imaging

In 1995, we used volumetric magnetic resonance imaging (MRI) and found that normal hippocampal right > left asymmetry was diminished in non-demented elderly subjects [52], and that hippocampal and amygdaloid damage was greater in AD patients carrying the ϵ4 allele despite equal global cognitive severity of the disease [30]. This atrophy observed in AD patients was correlated with tests assessing delayed memory and the performance of homozygotic ϵ4 carriers in these tests was inferior to

Cerebral perfusion and metabolism

There is also an increasing number of studies that have examined how the ApoE genotype can influence regional cerebral blood flow (rCBF) or glucose metabolism (rCMRGl).

In 1995, Small et al. [49] measured rCMRGl from cognitively normal subjects who fulfilled the criteria for age-associated memory impairment and had a well-documented family history of AD. They found decreased parietal metabolism and left-right asymmetry in subjects carrying the ϵ4 allele. Other regions of the brain were not

Discussion

In this review, we propose that ApoE is responsible for the region-specific changes in the AD brain, and that this may also be the case in cognitively normal subjects. Currently, it seems that ApoE ϵ4 allele is linked to increased, and perhaps asymmetric, MTL damage. Not all the studies that have addressed the question of MTL damage in relation to the ϵ4 allele have detected significantly smaller or asymmetrical patterns of the hippocampal volumes. However, in each of the reviewed studies,

Acknowledgements

This study was supported by the Research Council for Health of the Academy of Finland.

References (59)

  • M. Riekkinen et al.

    Tetrahydroaminoacridine improves the recency effect in Alzheimer’s disease

    Neuroscience

    (1998)
  • P. Sachdev et al.

    Longitudinal study of cerebral blood flow in Alzheimer’s disease using single photon emission tomography

    Psychiat Res -Neuroim

    (1997)
  • H. Soininen et al.

    A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ϵ4 allele

    Neurosci Lett

    (1995)
  • H. Tohgi et al.

    Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ϵ4 allele

    Neurosci Lett

    (1997)
  • P.T. Xu et al.

    Specific regional transcription of apolipoprotein E in human brain neurons

    Am J Pathol

    (1999)
  • K. Amar et al.

    Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population

    Int J Geriatr Psychiatry

    (1998)
  • S.N. Azher et al.

    Does Apo ϵ4 correlate with MRI changes in Alzheimer’s disease?

    Neurology

    (1999)
  • J.P. Blass

    Pathophysiology of the Alzheimer’s syndrome

    Neurology

    (1993)
  • K. Blennow et al.

    Synaptic pathology in Alzheimer’s diseaserelation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele

    J Neural Transm Gen Sect

    (1996)
  • L. Bronge et al.

    White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype

    Dement Geriatr Cogn Disord

    (1999)
  • E.H. Corder et al.

    No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes

    Arch Neurol

    (1997)
  • S. Craft et al.

    Accelerated decline in apolipoprotein E ϵ4 homozygotes with Alzheimer’s disease

    Neurology

    (1998)
  • G. Dal Forno et al.

    Apolipoprotein E genotype and rate of decline in probable Alzheimer’s disease

    Arch Neurol

    (1996)
  • N.C. Fox et al.

    Presymptomatic hippocampal atrophy in Alzheimer’s disease. A longitudinal MRI study

    Brain

    (1996)
  • G.B. Frisoni et al.

    Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer’s disease

    Ann Neurol

    (1995)
  • C. Geroldi et al.

    Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer’s disease. A volumetric MRI study

    J Neurol Neurosurg Psychiatry

    (2000)
  • C. Geroldi et al.

    ApoE ϵ4 is associated with less frontal and more medial temporal lobe atrophy in AD

    Neurology

    (1999)
  • T. Gomez–Isla et al.

    Clinical and pathological correlates of apolipoprotein E ϵ4 in Alzheimer’s disease

    Ann Neurol

    (1996)
  • J.H. Growdon et al.

    Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer’s disease

    Neurology

    (1996)
  • Cited by (50)

    • A novel voxel-based method to estimate cortical sulci width and its application to compare patients with Alzheimer's disease to controls

      2020, NeuroImage
      Citation Excerpt :

      The goal of this section is to determine whether the sulcal width descriptors obtained using the proposed method can assess differences between a group of patients with AD and a group of matched controls. The decision to test the method using this dataset was made because AD causes a significant loss of gray matter (Lehtovirta et al., 2000; DeCarli, 2000; Karas et al., 2004); some sulci are thus expected to broaden (Liu et al., 2012). The dataset, obtained from the MIRIAD (Malone et al., 2012), includes MRI scans taken from 66 subjects on the same 1.5 T Signa MRI scanner (GE Medical systems, Milwaukee, WI).

    • Associations between the self-reported frequency of hearing chemical alarms in theater and regional brain volume in Gulf War Veterans

      2016, NeuroToxicology
      Citation Excerpt :

      Other exclusion criteria were neurological illness, head trauma with loss of consciousness greater than 10 min, medical disorders affecting brain function, and conditions contradictory for MRI. Because the apolipoprotein E (APOE) ε4 allele, the strongest genetic risk factor for Alzheimer’s disease (AD, Harold et al., 2009; Lambert et al., 2009), has demonstrated a particular phenotype of middle temporal lobe atrophy (Lehtovirta et al., 2000), we controlled for APOE genotype in our analyses to rule out the possibility that any associations between hearing chemical alarms and regional brain volume was independent of the genetic risk for AD. APOE genotype data was available for 69/90 participants.

    • Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: Early right hippocampal NAA/Cr loss in mildly impaired subjects

      2008, Psychiatry Research - Neuroimaging
      Citation Excerpt :

      Volumetric magnetic resonance imaging (MRI) measures of medial temporal lobe structures have been studied and found to be very useful in predicting conversion from MCI to AD. Volumetric MRI studies have found more pronounced atrophy in the right vs. the left hippocampus among subjects at genetic risk for AD (Soininen et al., 1995; Lehtovirta et al., 2000; Tapiola et al., 2008) and in age-associated memory impairment, a possible precursor to MCI (Soininen et al., 1994; Mega et al., 2002). These methods are labor intensive, however, and not suitable as a screening measure in the clinic.

    View all citing articles on Scopus
    View full text